<DOC>
	<DOCNO>NCT02946463</DOCNO>
	<brief_summary>The purpose study ass ALXN1210 compare eculizumab adult patient PNH previously use complement inhibitor .</brief_summary>
	<brief_title>ALXN1210 Versus Eculizumab Complement Inhibitor Treatment-Naïve Adult Patients With Paroxysmal Nocturnal Hemoglobinuria ( PNH )</brief_title>
	<detailed_description />
	<mesh_term>Hemoglobinuria , Paroxysmal</mesh_term>
	<mesh_term>Hemoglobinuria</mesh_term>
	<mesh_term>Complement System Proteins</mesh_term>
	<mesh_term>Complement Inactivating Agents</mesh_term>
	<criteria>1 . Male female ≥ 18 year age . 2 . PNH diagnosis confirm documented highsensitivity flow cytometry . 3 . Presence 1 follow PNHrelated sign symptom within 3 month Screening : fatigue , hemoglobinuria , abdominal pain , shortness breath ( dyspnea ) , anemia ( hemoglobin &lt; 10 g/dL ) , history major adverse vascular event ( include thrombosis ) , dysphagia , erectile dysfunction ; history pRBC transfusion due PNH . 4 . LDH level ≥ 1.5 × ULN screen . 5 . Documented meningococcal vaccination 3 year prior , time , initiate study treatment . 6 . Female patient childbearing potential must use highly effective contraception start screen continue least 8 month last dose ALXN1210 . 7 . Willing able give write informed consent comply study visit schedule . 1 . Treatment complement inhibitor time . 2 . History bone marrow transplantation . 3 . Body weight &lt; 40 kilogram . 4 . Females pregnant , breastfeed positive pregnancy test screen Day 1 . 5 . Participation another interventional clinical study use experimental therapy within 30 day initiation study drug Day 1 study within 5 halflives investigational product , whichever great . 6 . History ongoing major cardiac , pulmonary , renal , endocrine , hepatic disease , opinion investigator sponsor , would preclude participation . 7 . Unstable medical condition ( eg , myocardial ischemia , active gastrointestinal bleed , severe congestive heart failure , anticipate need major surgery within 6 month randomization , coexist chronic anemia unrelated PNH ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>